SEC Form 4 · accession 0001237899-15-000022
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas S McCorkle
Officer — VP Controller and Asst Treasur
Period of report
Feb 27, 2015
Accepted (ET)
Feb 27, 2015 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | S | 3,000 | $416.24 | D | 4,481 | D | |
| Common Stock | holding | — | — | — | 4,129 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents volume-weighted average price of sales of 3,000 shares of Company stock on February 27, 2015 at prices ranging from $416.00 to $416.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 27, 2015 at each separate price.